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1. Introduction 
Venoms of many species of snakes belonging to the 
family Elapidae (cobras, mambas, tiger snakes, black 
snakes, taipan, etc.) and Hydrophiidae (sea snakes) are 
highly toxic and produce flaccid paralysis and respira- 
tory failure [ 1 ] . These effects have been attributed to 
the so-called ‘neurotoxins’ contained in the venoms. 
The toxins contained in the venom of Naja naja have 
been demonstrated to show a great affinity to the 
acetylcholine receptors on the motor endplate. Unlike 
the crude cobra venom, cobra neurotoxin produces 
neuromuscular block without causing muscle contracture 
or inhibition of the muscle response to direct stimula- 
tion even which high concentrations. The blockade 
produced by the neurotoxin can be reversed by neo- 
stigmine. Pretreatment with d-tubocurarine can protect 
the chick biventer cervicis muscle from the neuro- 
muscular blocking action of cobra neurotoxins. 
In 1971, Karlsson et al. [2] reported that the 
venom of Naja naja naja, or spectacled Indian cobra 
contained two principal neurotoxins, which differ 
only by a serine/isoleucine substitution. In the course 
of the study of biologically active principles in the 
venom of N& naja, several neurotoxic proteins 
including Types I and II were isolated by gel filtration 
on Sephadex G-50 followed by chromatography on 
CM-cellulose [3]. Among these neurotoxins, toxins A 
and B were the major neurotoxins and the content 
of these toxins varied considerably with the prepara- 
tion of the crude venom. 
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Studies on the chemical properties of toxin B 
have established its amino acid composition and 
revealed that toxins B and A had the same amino acid 
composition except that the former had one more 
serine residue and one less isoleucine residue than the 
latter. Accordingly, toxin A [4] corresponded to 
Naja naja naja 3 neurotoxin which was isolated by 
Karlsson et al. [2] and toxin B to Naja naja naja 4 
neurotoxin, although the subspecies of their origins 
were different. Knowledge of the sequence of toxin B 
is required in order to determine the location of the 
essential amino acid residues required for the main- 
tenance of active conformation of this type. The 
purpose of this communication is to report the 
complete covalent structure of toxin B. 
2. Materials and methods 
The crude lyophilized Naja naja venom was the 
product of the Haffkine Institute, Bombay, India, and 
of Sigma Chemical Co., Ltd., USA. Trypsin and 
cu-chymotrypsin were the products of Worthington 
Biochemical Corp., USA. Acid cardoxypeptidase 
produced by Penicillium janthinellum was given by 
Dr E. Ichishima to Tokyo Noko University. 
Toxin B used in this study was prepared from the 
venom of Naja naja by gel filtration on Sephadex G-50 
followed by CM-cellulose. The venom dissolved in 1% 
acetic acid was applied to a column of Sephadex G-50 
equilibrated with the same elution medium. Due to the 
molecular weight of other known snake venom neuro- 
toxins and its strongly lethal toxicity, the protein 
fraction with molecular weight of about 6000-7500 
was freeze-dried and applied to a CM-cellulose column 
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equilibrated with a 0.005 M sodium acetate buffer, 
pH 5.8. A gradient (from 0.005 M sodium acetate buffer, 
pH 5.8, to 0.5 M sodium acetate buffer, pH 6.5) was 
then applied at the top of the column. Each fraction 
was pooled, lyophilized and then gel-filtered to remove 
sodium acetate. Homogeneity was examined by poly- 
acrylamide disc-gel electrophoresis using 15% gels at 
pH 2.3 according to the method of Davis [5] , and 
by sodium dodecyl sulfate disc gel electrophoresis 
according to the method of Weber and Osborn [6]. 
The isoelectric point was determined by the method 
of Vesterberg and Svensson [7] using 0.5% ampho- 
lytes, pH 3- 10, and a sucrose gradient at 4’C for 20 h. 
Its LDso in mice (NH strain) by intraperitoneal 
injection was determined according to the method of 
Litchlield and Wilcoxon [8]. Rat phrenic nerve-dia- 
phragm preparation [9] was used for testing its action 
on the neuromuscular junction. The reductin and 
S-carboxymethylation (RCM) of toxin B was perform- 
ed as described by Crestfield et al. [ 1 l] . Amino acid 
analysis of the toxin and the tryptic and chymotryptic 
peptides were carried out by standard method using a 
Hitachi KLA 3B automatic amino acid analyzer. 
Sequential degradations were conducted by the Edman 
procedure modified by Iwanaga et al. [lo], and the 
phenylthiohydantoin amino acids were identified by 
thin layer chromatography [12,13]. The carboxy- 
terminal sequence of RCM-toxin B was determined by 
the use of acid carboxypeptidase [141. The carboxy- 
termini of chymotryptic peptide (C-I) and RCM-toxin B 
were determined by hydrazinolysis [ 151. Trypsin and 
chymotrypsin digestions were carried out at 37°C for 
3 h in 0.1 M ammonium bicarbonate buffer, pH 7.9, 
using a weight ratio of enzyme to substrate of 1: 50. 
These peptides derived by proteolytic enzymes were 
separated by a combination of gel filtration on a 
column of Sephadex G-l 5 using 0.2% acetic acid as 
the eluent and high voltage paper electrophoresis 
using a buffer (pyridine/acetic acid/water=l:10:289, 
by vol) pH 3.6, and descending paper chromatography 
using a solvent system (1 -butanol/acetic acidlpyridinel 
water=l5:3:10: 12, by vol.) 
3. Results and discussion 
Toxin B was obtained in a yield of about 7% 
from the crude venom of Naja naja. When injected 
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intraperitoneally in mice, its LDso was 0.09 yg/g body 
weight. The purified toxin B was homogeneous by 
the criteria of polyacrylamide disc-gel electrophoresis 
and the isoelectric point was pH 9.3. The toxin 
decreased the single twitches of the diaphragm elicited 
by phrenic nerve stimulation. The molecular weight 
of toxin B was estimated by gel filtration to be about 
7000. Based on this value and on the amino acid 
composition, one molecule of the toxin was composed 
of 71 amino acid residues: Asp 8.61, Thr 8.30, Ser 
3.60, Glu 1.13, Pro 5.38, Gly 4.60, Ala 1.85, Half- 
Cys 8.40, Val3.40, Be 3.60, Leu 1.00, Tyr 1.01, 
Phe 2.96, Trp 1, Lys 3.64, His 0.82, Arg 5.60. 
Tryptophan was determined spectrophotometrically. 
The thirty three stepwise Edman degradations of 
RCM-toxin B revealed the amino terminal sequence 
to be 
H-Ile-Arg-Cys-Phe-Ile-Thr-Pro-Asp-Ile- 
Thr-Ser-Lys-Asp-Cys-Pro-Asn-Gly-His-Val- 
Cys-Tyr-Thr-Lys-Thr-Trp-Cys-Asp-Gly- 
Phe-Cys-Ser-Ser-Arg- - - 
The carboxy-terminal sequence was examined by the 
use of acid carboxypeptidase isolated from the culture 
fluid of Penicillium janthinellum and by hydrazinolysis. 
From the results, the carboxy-terminal sequence was 
determined to be 
-Arg-Lys-Arg-Pro-OH 
Then, RCM-toxin B was digested by chymotrypsin 
and the resulting peptides were separated by gel filtra- 
tion on a Sephadex G-l 5 column and the fractions 
were assayed for absorbances at 226 and 280 nm. 
Further purification of heterogeneous fraction (C-IV) 
was made by high voltage paper electrophoresis. In 
the chymotrypsin digestion of RCM-toxin B, it was 
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observed that the peptide bond -Thr-Arg- was 
hyrolyzed considerably but no other threonyl peptide 
bonds were. The amino acid compositions and the 
yields of the chymotryptic peptides are given in table 1, 
and the amino acid sequences of these peptides 
elucidated by the Edman degradation are shown in 
table 2. The peptide numbers do not refer to the 
order in which their location in the sequence starting 
from the amino-terminal end but to the order of elu- 
Volume 71, number 1 FEBSLETTERS November 1976 
Table 1 
Amino acid compositions of chymotryptic peptides derived from RCM-toxin B 
Amino acid C-I C-II C-III C-IV-1 C-IV-2 c-v 
CMCysteine 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Lysine 
Histidine 
Arginine 
Tryptophan 
5.90 (6) 2.06 (2) 
4.90 (5) 2.90 (3) 
4.92 (5) 2.01 (2) 
2.54 (3) 1 .oo (1) 
1.12 (1) 
2.80 (3) 1.85 (2) 1.14 (1) 
2.68 (3) 1.00 (1) - 
1.96 (2) 
2.66 (3) 1.07 (1) 
1.13 (1) 1.64 (2) 
0.96 (1) 
0.77 (1) 
1.00 (1) - 
0.85 (1) 0.90 (1) 1 .oo (1) - 
0.74 (1) 
2.69 (3) 2.04 (2) 
1.02 (1) 1.02 (1) 
1.08 (1) 
1.93 (2) 
0.90 (1) 
0.94 (1) 
1.00 (1) 1.00 (1) - - 
1.00 (1) - 
0.99 (1) 
+ (1) 
Yield (%) 69 67 75 88 89 85 
Position 30-67 5-21 68-71 l-4 26-29 22-25 
The values of the amino acids underlined were taken as 1.0. The numbers in parentheses 
represent he nearest integers. Tryptophan was determined spectrophotometricaly. 
Table 2 
Chymotryptic peptides from RCM-toxin B 
Peptide No. Sequence 
C-I Cys-Ser-Ser-Arg-Gly-Lys-Arg-Val-Asp-Leu-Gly-Cys-Ala-Ala- 
~---,--+----_,-t-----,3 
T_lf-z-2-Thr-Val-A2-T2-Gly-Vr-Asp-I&G>-Cys-Cz- 
Ser-Thr, (Asp, zp, CG, Asp, Pro, PhTPro)-5 
- 
+--+ 
C-II Ile-Thr-Pro-Asp-Ile-Thr-Ser-Lys-Asp-Cys-Pro-Asn-Gly-His 
+-t-t---t---*~--~+---*---+ 
Val-Cys-Tyr 
_A-+ 
C-III 9-Lz-%-Pro 
GIV- 1 Be- Arg-Cys-G 
C-IV-2 zs-zp-Gy-Ge 
c-v ;h7-L;-G-T; +-+- 
Right- and left-handed arrows showed that the sequence was elucidated, respectively, by Edman 
degradation or by the hydrazinolysis. 
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tion from a Sephadex column. The various peptides 
were designated by the symbol C-. 
Chymotryptic peptides C-I and C-II with large 
molecular weight were subjected to the digestion by 
the use of trypsin. The resulting peptides were isolated 
by high voltage paper electrophoresis and their purities 
were examined by paper chromatography. The amino 
acid compositions of the tryptic peptides are given in 
table 3, and the amino acid sequences elucidated by 
the Edman degradation are shown in table 4. The 
peptides derived from the trypsin digestion were 
designated by the symbol T-. 
Table 3 
Amino acid compositions of tryptic peptides derived from chymotryptic peptides C-II and C-I 
Amino acid C-I-T-1 C-I-T-2 C-I-T-3 C-I-T-4 C-II-T-l C-II-T-2 
CM-Cysteine 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Lysine 
Histidine 
Arginine 
Tryptophan 
Yield (%) 25 47 18 30 32 28 
Position 30-33 34-36 37-49 50-67 5-12 13-21 
1.01 (1) 2.15 (2) 
1.31 (1) 
2.00 (2) 
1.80 (2) 
0.95 (1) 
0.96 (1) 1.00 (1) 
1.54 (2) 
1.90 (2) 
3.04 (3) 
4.41 (4) 
3.22 (3) 
1.10 (1) 
1.32 (1) 
2.22 (2) 
1.30 (1) 
1.00 (1) 
0.90 (1) 
1.57 (2) 
1.12 (1) 2.08 (2) 
2.10 (2) 
1.18 (1) 0.77 (1) 
1.00 (1) - 
0.86 (1) 
1.71 (2) 
0.75 (1) 
0.62 (1) 
0.80 (1) 
1.00 (1) 
1.00 (1) 1.03 (1) 1.00 (1) 
1.00 (1) 
0.89 (1) 
The values of the amino acids underlined were taken as 1.0. The numbers in parentheses 
represent he nearest integers. 
Table 4 
Tryptic peptides from chymotryptic peptides C-I and C-II 
Peptide No. Sequence 
C-I-T-1 Cys-Ser-Ser-Arg ---+-- 
C-I-T-2 Gly-Lys-Afg 
C-I-T-3 g-A<-bLa-G2-Cys-Ala (Ala-Thr-Cys-Pro-Thr-Val-Arg) 
--+- 
C-I-T-4 T~-Gly-Val-Asp-Ile-Gln-Cys-Cys-Ser-Thr-Asp-Asp-Cys- 
Asp-P~-P~-~-~r 
-------+-~+- 
C-11-T-l (z-T<-P;-Asp-Ile-Thr-Ser-Lys) 
C-II-T-2 (Asp-Cys-Pro-Asn-Gly-His-Val-Cys-Tyr) 
Right-handed arrows showed that the sequence was elucidated by Edman degradation. 
The sequences in parentheses were determined from the amino acid compositions of the 
peptides and from data of the sequence analysis of RCM-toxin B and chymotryptic 
peptide C-I. 
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1’-+-D~-+-+‘--+‘-X-+“” 
H-Ile-Ar -Cys-Phe-Ile-Thr-Pro-Asp-Ile-Thr-Ser-Lys-~p-Cys-Pro- 
-_,-! ~-~---_)-+---_j---_$--_$----_)3-+--_)-+3 
t-- C-IV-l--J : 4 C-II,, 
i t-------C-11-T-1----------_) !- 
-C-11-T-2-i i ! I< 
i: 4oc 
i: 
----)-+----) 
Ser-~---&--Xyy_\ 
-Ar -Gl -L s-Ar -Val-Asp-Leu-Gly-Cys-AIa-Ala-Thr-Cys- 
-_)+++--_,--_j_)+~ 
~.--_,---n-*-~+C-.I. 
-C-I-T-l+ tC-I-T-2+ ; Y C-I-T-3 
T T 
50 60 
Pro-Thr-Val-s- Ile-Gln-Cys-Cys-Ser-Thr-Asp- 
------+?C 
------C-‘I_Tr4 ‘. l - 
+ 
70 
Asp-Cys-Pro-Phe-Pro-Thr-G-G-G-Pro-OH 
*T--, *-_) 
~-+---_) ) ;+ c-111+ 
) 
A 
Fig.1. Amino Acid Sequence of Toxin B from Indian Cobra Venom (Nuju naju). Horizontal arrows below amino acid residues 
denote the sequences ofchymotryptic and tryptic peptides. Right- and left-handed arrows how that the sequence was elucidated, 
respectively, by Edman degradation by the action of acid carboxypeptidase or by the hydrazinolysis. C and T represent the 
peptide bonds which were hydrolyzed by the action of chymotrypsin, respectively. 
There are overlaps between the tryptic and chymo- 
tryptic peptides which allowed the unequivocal place- 
ment of the remainder of the peptides. Referring to 
the amino- and the carboxy-terminal sequences of 
RCM-toxin B, the complete covalent structure of 
toxin B was elucidated as shown in fig. 1. The sequence 
of toxin B indicated that the molecular weight of the 
protein consisting of 71 amino acid residues, cross- 
linked by five disulfide bridges, was 78 12. 
There is a remarkable similarity in the primary 
structure between toxins B and toxin A [4]. Toxin B 
differs from toxin A only in the presence of serine 
residue in place of isoleucine residue at position 32. 
The replacement can be explained by a single base 
replacement in the triplet codes (AGU to AUU or 
AGC to AUC). 
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